In the context of NASH, activation of NLRP3 inflammasome is triggered by lipotoxicity, organelle stress, and hepatocyte death, while exacerbates hepatic steatosis [19]. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.